Cancer cells from various solid tumor types were discovered to upregulate MICA/B and ULPB1–3 [28,29,30,31], whereas they downregulated the KIR2D ligands HLA-ABC and HLA-G [32,33,34,35], suggesting a higher sensitivity to NK cell-mediated cytotoxicity. Here, MICA is linked to cancer.